Clinical Trial Update: Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing romiplostim plus dexamethasone versus dexamethasone alone in newly diagnosed primary immune thrombocytopenia; currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Decadron (Dexamethasone)
• Nplate (romiplostim)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Primary Immune Thrombocytopenia | Phase 3 | Status: ACTIVE_NOT_RECRUITING